vs
Montrose Environmental Group, Inc.(MEG)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Montrose Environmental Group, Inc.的1.0倍($197.9M vs $193.3M),REPLIGEN CORP净利率更高(6.7% vs -4.3%,领先11.0%),REPLIGEN CORP同比增速更快(13.6% vs 2.2%),Montrose Environmental Group, Inc.自由现金流更多($46.5M vs $17.6M),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs 11.5%)
蒙特罗斯环境集团是一家美国跨国企业,主营各类环境服务,业务覆盖环境行业全产业链,可为公共部门及私营领域客户提供一体化支持。公司总部位于阿肯色州小石城,在美国特拉华州完成注册。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
MEG vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.0倍
$193.3M
营收增速更快
RGEN
高出11.4%
2.2%
净利率更高
RGEN
高出11.0%
-4.3%
自由现金流更多
MEG
多$29.0M
$17.6M
两年增速更快
RGEN
近两年复合增速
11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $193.3M | $197.9M |
| 净利润 | $-8.2M | $13.3M |
| 毛利率 | 38.6% | 52.5% |
| 营业利润率 | -1.3% | 9.0% |
| 净利率 | -4.3% | 6.7% |
| 营收同比 | 2.2% | 13.6% |
| 净利润同比 | 70.9% | 143.9% |
| 每股收益(稀释后) | $-0.13 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
MEG
RGEN
| Q4 25 | $193.3M | $197.9M | ||
| Q3 25 | $224.9M | $188.8M | ||
| Q2 25 | $234.5M | $182.4M | ||
| Q1 25 | $177.8M | $169.2M | ||
| Q4 24 | $189.1M | $174.1M | ||
| Q3 24 | $178.7M | $154.9M | ||
| Q2 24 | $173.3M | $154.1M | ||
| Q1 24 | $155.3M | $151.3M |
净利润
MEG
RGEN
| Q4 25 | $-8.2M | $13.3M | ||
| Q3 25 | $8.4M | $14.9M | ||
| Q2 25 | $18.4M | $14.9M | ||
| Q1 25 | $-19.4M | $5.8M | ||
| Q4 24 | $-28.2M | $-30.3M | ||
| Q3 24 | $-10.6M | $-654.0K | ||
| Q2 24 | $-10.2M | $3.3M | ||
| Q1 24 | $-13.4M | $2.1M |
毛利率
MEG
RGEN
| Q4 25 | 38.6% | 52.5% | ||
| Q3 25 | 39.4% | 53.2% | ||
| Q2 25 | 43.4% | 50.0% | ||
| Q1 25 | 39.0% | 53.6% | ||
| Q4 24 | 40.8% | 26.1% | ||
| Q3 24 | 40.9% | 50.0% | ||
| Q2 24 | 39.9% | 49.8% | ||
| Q1 24 | 37.8% | 49.5% |
营业利润率
MEG
RGEN
| Q4 25 | -1.3% | 9.0% | ||
| Q3 25 | 4.4% | 8.9% | ||
| Q2 25 | 6.4% | 7.6% | ||
| Q1 25 | -5.9% | 3.9% | ||
| Q4 24 | -12.1% | -17.7% | ||
| Q3 24 | -0.6% | -5.1% | ||
| Q2 24 | -1.5% | 1.0% | ||
| Q1 24 | -6.5% | 1.3% |
净利率
MEG
RGEN
| Q4 25 | -4.3% | 6.7% | ||
| Q3 25 | 3.7% | 7.9% | ||
| Q2 25 | 7.8% | 8.2% | ||
| Q1 25 | -10.9% | 3.4% | ||
| Q4 24 | -14.9% | -17.4% | ||
| Q3 24 | -5.9% | -0.4% | ||
| Q2 24 | -5.9% | 2.2% | ||
| Q1 24 | -8.6% | 1.4% |
每股收益(稀释后)
MEG
RGEN
| Q4 25 | $-0.13 | $0.24 | ||
| Q3 25 | $0.21 | $0.26 | ||
| Q2 25 | $0.42 | $0.26 | ||
| Q1 25 | $-0.64 | $0.10 | ||
| Q4 24 | $-0.91 | $-0.55 | ||
| Q3 24 | $-0.39 | $-0.01 | ||
| Q2 24 | $-0.39 | $0.06 | ||
| Q1 24 | $-0.53 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $11.2M | $767.6M |
| 总债务越低越好 | $277.1M | $542.2M |
| 股东权益账面价值 | $451.2M | $2.1B |
| 总资产 | $981.3M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.61× | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
MEG
RGEN
| Q4 25 | $11.2M | $767.6M | ||
| Q3 25 | $6.7M | $748.7M | ||
| Q2 25 | $10.5M | $708.9M | ||
| Q1 25 | $30.3M | $697.2M | ||
| Q4 24 | $12.9M | $757.4M | ||
| Q3 24 | $13.0M | $784.0M | ||
| Q2 24 | $16.9M | $809.1M | ||
| Q1 24 | $9.5M | $780.6M |
总债务
MEG
RGEN
| Q4 25 | $277.1M | $542.2M | ||
| Q3 25 | $302.4M | $537.9M | ||
| Q2 25 | $264.6M | — | ||
| Q1 25 | $235.6M | — | ||
| Q4 24 | $204.8M | $525.6M | ||
| Q3 24 | $233.0M | — | ||
| Q2 24 | $188.7M | — | ||
| Q1 24 | $280.9M | — |
股东权益
MEG
RGEN
| Q4 25 | $451.2M | $2.1B | ||
| Q3 25 | $458.7M | $2.1B | ||
| Q2 25 | $470.3M | $2.1B | ||
| Q1 25 | $444.1M | $2.0B | ||
| Q4 24 | $446.3M | $2.0B | ||
| Q3 24 | $449.2M | $2.0B | ||
| Q2 24 | $448.8M | $2.0B | ||
| Q1 24 | $324.5M | $2.0B |
总资产
MEG
RGEN
| Q4 25 | $981.3M | $2.9B | ||
| Q3 25 | $985.7M | $2.9B | ||
| Q2 25 | $998.1M | $2.9B | ||
| Q1 25 | $992.2M | $2.9B | ||
| Q4 24 | $990.4M | $2.8B | ||
| Q3 24 | $1.0B | $2.8B | ||
| Q2 24 | $943.9M | $2.9B | ||
| Q1 24 | $918.1M | $2.8B |
负债/权益比
MEG
RGEN
| Q4 25 | 0.61× | 0.26× | ||
| Q3 25 | 0.66× | 0.26× | ||
| Q2 25 | 0.56× | — | ||
| Q1 25 | 0.53× | — | ||
| Q4 24 | 0.46× | 0.27× | ||
| Q3 24 | 0.52× | — | ||
| Q2 24 | 0.42× | — | ||
| Q1 24 | 0.87× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $51.9M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $46.5M | $17.6M |
| 自由现金流率自由现金流/营收 | 24.1% | 8.9% |
| 资本支出强度资本支出/营收 | 2.8% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $91.2M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
MEG
RGEN
| Q4 25 | $51.9M | $25.7M | ||
| Q3 25 | $28.1M | $48.1M | ||
| Q2 25 | $21.9M | $28.6M | ||
| Q1 25 | $5.5M | $15.0M | ||
| Q4 24 | $32.0M | $39.2M | ||
| Q3 24 | $11.4M | $49.3M | ||
| Q2 24 | $894.0K | $42.2M | ||
| Q1 24 | $-22.0M | $44.7M |
自由现金流
MEG
RGEN
| Q4 25 | $46.5M | $17.6M | ||
| Q3 25 | $22.3M | $43.4M | ||
| Q2 25 | $19.9M | $21.5M | ||
| Q1 25 | $2.4M | $11.4M | ||
| Q4 24 | $29.7M | $33.6M | ||
| Q3 24 | $10.2M | $42.3M | ||
| Q2 24 | $-9.8M | $37.4M | ||
| Q1 24 | $-29.3M | $36.4M |
自由现金流率
MEG
RGEN
| Q4 25 | 24.1% | 8.9% | ||
| Q3 25 | 9.9% | 23.0% | ||
| Q2 25 | 8.5% | 11.8% | ||
| Q1 25 | 1.3% | 6.8% | ||
| Q4 24 | 15.7% | 19.3% | ||
| Q3 24 | 5.7% | 27.3% | ||
| Q2 24 | -5.6% | 24.3% | ||
| Q1 24 | -18.9% | 24.0% |
资本支出强度
MEG
RGEN
| Q4 25 | 2.8% | 4.1% | ||
| Q3 25 | 2.6% | 2.5% | ||
| Q2 25 | 0.8% | 3.9% | ||
| Q1 25 | 1.8% | 2.1% | ||
| Q4 24 | 1.2% | 3.2% | ||
| Q3 24 | 0.6% | 4.5% | ||
| Q2 24 | 6.1% | 3.1% | ||
| Q1 24 | 4.7% | 5.5% |
现金转化率
MEG
RGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 3.36× | 3.23× | ||
| Q2 25 | 1.19× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图